DAX+0,80 % EUR/USD+0,68 % Gold+1,55 % Öl (Brent)+2,15 %

DGAP-News: Mediclin AG english = - 500 Beiträge pro Seite



Beitrag schreiben

Begriffe und/oder Benutzer

 

MediClin AG acquires Westdeutsche Cyclotron GmbH

Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. --------------------------------------------------------------------------------

- Strengthening the Clinics in the Bonn area - High technology examination procedures established

Bonn, 21. January 2002. With the purchase of the pharmaceutical company Westdeutsche Cyclotron GmbH (WCG) in Bonn, MediClin AG integrated a manufacturer of state-of-the-art medical products into the services it provides. WCG was initially engaged in the production and development of radio-pharmacological products necessary for nuclear-medical diagnostics. WCG generated sales of Euro 3.2 million in 2001.

WCG, located in Bonn, is primarily specialized in the production of substances used in positron-emission tomography (PET). PET is a promising procedure that permits exact and early identification of initial carcinomas and metastases, and also of cardiological and neurological conditions with only very little stress involved for the patient. Experts estimate that PET will in future be established as a standard procedure in patient care at leading medical institutions.

This examination procedure is part of the diagnosis spectrum of the Robert Janker Clinic in Bonn, a clinic specializing in radiology; the clinic, an institution of MediClin AG, is engaged in the treatment of carcinosis, vascular diseases and rachiopathy in particular. The field of nuclear medicine is one of the specialist areas of growing significance here.

With the acquisition of Westdeutsche Cyclotron GmbH, MediClin AG continues its investments in the future market of high technology medicine and in the concept of regional networking of high performance facilities. Mediclin"s aim is to provide optimal treatment for its patients in both medical and economic terms. MediClin is certain that this aim can be achieved through close coordination between all necessary services of modern medicine.

About MediClin (Symbol: MED, WKN: 659 510) MediClin AG is a nation-wide clinic operator with head office in Frankfurt The administrative headquarters of 43 clinics and facilities is in Offenburg. The MediClin facilities are distributed over 35 locations in 11 federal states and have a total capacity of over 9,000 beds. They include general hospitals, special treatment facilities, specialised hospitals, clinics for medical rehabilitation/subsequent nursing treatment and nursing facilities. Two facilities are run in the form of management agreements; MediClin has more than 9,500 employees of whom over 750 are physicians in various specialist fields

For more information please contact: MediClin GmbH Investor Relations Alexandra Muehr Wilhelm-Leuschner-Strasse 9-11 60329 Frankfurt am Main

Phone: +49 (0) 69 256002-13 Fax: +49 (0) 69 256002-69 Email: alexandra.muehr@mediclin.de www.mediclin.de end of message, (c)DGAP 21.01.2002 -------------------------------------------------------------------------------- WKN: 659510; ISIN: DE0006595101; Index: Listed: Amtlicher Handel in Frankfurt (SMAX); Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart 211138 Jän 02



Autor: DGAP import (),11:41 21.01.2002



Beitrag zu dieser Diskussion schreiben


Es handelt sich hier um einen ältere Diskussionen, daher ist das Schreiben in dieser Diskussion nicht mehr möglich. Bitte eröffnen Sie hier ein neue Diskussion.